PURPOSE: Scleroderma (SSc) is rare, and few studies have examined self-efficacy in persons with the disease. Self-efficacy is one precursor that has been shown to initiate changes in behaviour when managing chronic disease. The objective of this study was to explore the levels of self-efficacy in persons with SSc, compare self-efficacy in persons with limited or diffuse SSc and determine correlations between self-efficacy, physical function and psychological variables. METHODS: Sixty-two participants with SSc completed measures assessing self-efficacy, depression, fatigue, pain, hand function and activity limitations. The mean age of participants was 52.9 years. The mean educational level was 15.8 years. Sixty-seven per cent were married and 87.1% were women. Thirty participants had diffuse SSc, 27 had limited SSc and five were unclassified. RESULTS: The only significant differences between the two disease subtypes were in hand function and self-efficacy function subscale scores. Total self-efficacy scores significantly correlated with marital status, employment, self-reported health, depression, functional ability, fatigue, pain and hand function. Similarly, self-efficacy function scale scores correlated significantly with employment, self-reported health, functional ability, pain and hand function. Self-efficacy pain scale scores correlated significantly with fatigability. The self-efficacy other scale scores correlated significantly with depression and fatigability. Participants with higher levels of pain and depression, more fatigue, more general disability and more hand disability had lower self-efficacy. CONCLUSION: Self-efficacy correlates with physical function and psychological variables, and could predict how patients manage their health. Self-efficacy may increase through participation in educational programmes focusing on self-management of these variables.
PURPOSE:Scleroderma (SSc) is rare, and few studies have examined self-efficacy in persons with the disease. Self-efficacy is one precursor that has been shown to initiate changes in behaviour when managing chronic disease. The objective of this study was to explore the levels of self-efficacy in persons with SSc, compare self-efficacy in persons with limited or diffuse SSc and determine correlations between self-efficacy, physical function and psychological variables. METHODS: Sixty-two participants with SSc completed measures assessing self-efficacy, depression, fatigue, pain, hand function and activity limitations. The mean age of participants was 52.9 years. The mean educational level was 15.8 years. Sixty-seven per cent were married and 87.1% were women. Thirty participants had diffuse SSc, 27 had limited SSc and five were unclassified. RESULTS: The only significant differences between the two disease subtypes were in hand function and self-efficacy function subscale scores. Total self-efficacy scores significantly correlated with marital status, employment, self-reported health, depression, functional ability, fatigue, pain and hand function. Similarly, self-efficacy function scale scores correlated significantly with employment, self-reported health, functional ability, pain and hand function. Self-efficacy pain scale scores correlated significantly with fatigability. The self-efficacy other scale scores correlated significantly with depression and fatigability. Participants with higher levels of pain and depression, more fatigue, more general disability and more hand disability had lower self-efficacy. CONCLUSION: Self-efficacy correlates with physical function and psychological variables, and could predict how patients manage their health. Self-efficacy may increase through participation in educational programmes focusing on self-management of these variables.
Authors: A Silman; A Akesson; J Newman; H Henriksson; G Sandquist; M Nihill; S Palfrey; R Lomas; F Wollheim; C Black Journal: J Rheumatol Date: 1998-01 Impact factor: 4.666
Authors: Dinesh Khanna; Mansoor Ahmed; Daniel E Furst; Shaari S Ginsburg; Grace S Park; Richard Hornung; Joel Tsevat Journal: Arthritis Rheum Date: 2007-02-15
Authors: Luc Mouthon; François Rannou; Alice Bérezné; Christian Pagnoux; Philippe Guilpain; François Goldwasser; Michel Revel; Loïc Guillevin; Jacques Fermanian; Serge Poiraudeau Journal: Arthritis Rheum Date: 2008-07-15
Authors: Sarah Hewlett; Zoë Cockshott; Celia Almeida; Pam Richards; Rob Lowe; Rosemary Greenwood; John Kirwan Journal: Musculoskeletal Care Date: 2008-03
Authors: Leticia Leon; Lydia Abasolo; Marta Redondo; Miguel Angel Perez-Nieto; Luis Rodriguez-Rodriguez; Maria Isabel Casado; Rafael Curbelo; Juan Angel Jover Journal: Rheumatol Int Date: 2013-09-27 Impact factor: 2.631
Authors: Brian W Pennarola; Angie Mae Rodday; Kristin Bingen; Lisa A Schwartz; Sunita K Patel; Karen L Syrjala; Deborah K Mayer; Sara J Ratichek; Eva C Guinan; Mary Jo Kupst; Judith H Hibbard; Susan K Parsons Journal: Support Care Cancer Date: 2014-12-18 Impact factor: 3.603
Authors: Seher Arat; Jan L Lenaerts; Ellen De Langhe; Patrick Verschueren; Philip Moons; Joris Vandenberghe; Veerle Taelman; Rene Westhovens Journal: Lupus Sci Med Date: 2017-11-14
Authors: Linda Kwakkenbos; Erin Arthurs; Frank H J van den Hoogen; Marie Hudson; Wim G J M van Lankveld; Murray Baron; Cornelia H M van den Ende; Brett D Thombs Journal: PLoS One Date: 2013-01-11 Impact factor: 3.240
Authors: Robyn K Wojeck; Susan G Silva; Donald E Bailey; Mitchell R Knisely; Linda Kwakkenbos; Marie-Eve Carrier; Warren R Nielson; Susan J Bartlett; Janet Pope; Brett D Thombs Journal: Nurs Res Date: 2021 Set/Oct 01 Impact factor: 2.381